For the last 20 years, a dedicated group of Doctors and Researchers have been studying the pathogen Mycobacterium avium ssp paratuberculosis and its relationship to Crohn’s disease and other diseases termed “autoimmune” diseases. For years, the prevailing view was that IBD was an autoimmune disease, which meant that the patient’s body was attacking itself due to ...
General Inflammatory Bowel Disease (IBD) and Crohn’s Information
Inflammatory Bowel Disease (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are ulcerative colitis and Crohn’s disease. In Crohn’s disease, inflammation can affect the entire digestive tract but is usually centered in the ileum (the final segment of the small intestine) and the beginning part of the colon (large intestine). Ulcerative colitis presents exclusively in the colon. Both illnesses are characterized by an abnormal response to the body’s immune system. They can occur at any age, but often initially develop in teenagers and young adults.
Phil – The Crohn’s Controversy
Watch as Phil lays out the research and controversy surrounding the anti-MAP treatment as he experiences it first hand.
The video shown here amplifies one success story and provides a nice overview of what is being done, some of the issues surrounding this treatment protocol and why the current medical professionals are reluctant to embrace this treatment.
[button link=”http://thecrohnsinfection.org/the-crohns-controversy” type=”big”] Click here to watch the video and view related links[/button]
John M. Aitken
John Aitken is a free-lance microbiologist based out of Christchurch, New Zealand and the senior director of Otakaro Pathways, Ltd. Prior to his current position, he has worked in medical microbiology for public and private providers for more than 40 years. In his “spare time” he has established a microbiological environmental testing laboratory.
His particular areas of interest are antimicrobial resistance and emerging bacterial infectious diseases. The majority of his work involves an understanding of the underlying relationships between microorganisms, plants, and animals.
Dr. William M. Chamberlin
Dr. William M. Chamberlin is a retired gastroenterologist who is currently conducting research into MAP. He received his medical degree from Tufts University and completed his residency in internal medicine at William Beaumont Army Medical Center. From there, he completed a fellowship in gastroenterology at Walter Reed Army Medical Center. His early work experience took him to positions in Thailand, Southern Australia, Papua New Guinea, Germany and Japan. He served 20 years in the U.S. Army Medical Corps with his last assignment being at Walter Reed Army Institute of Research where he studied the immune systems responses to microbial infections before settling into private practice. His primary research areas are Crohn’s disease, hormonal immune regulation, and emergence and evolution in biological systems and disease.
Dr. Amy Hermon-Taylor
Dr. Amy Hermon-Taylor is a doctor (GP) from Clapham in London, UK and is the daughter of Prof. John Hermon-Taylor who is leading the world with the development of a modern virally-vectored DNA vaccine against Mycobacterium avium subspecies paratuberculosis (MAP). Amy does not suffer with IBD herself but grew up with the fight to cure Crohn’s Disease as a topic of daily conversation. In gaining a degree in Natural Sciences (Cambridge 1996), a degree in Medicine (St. George’s Medical School, London 2001) and subsequently reading the literature on MAP in Crohn’s Disease extensively for herself, she has come to have a good understanding of the science underpinning the Vaccine research -as well as the integrity of the man behind it.
Patrick McLean
Patrick McLean holds a Bachelor of Science degree in Chemistry from the University of Minnesota. After four years in basic and applied research in protein nutrition, he moved into sales and marketing for J. Hungerford Smith Co., International Multifoods Corporation (US and Canada) and Catelli Ltd (Canada). In 1983 Patrick joined Ralston Purina Co. (Canada) and became Vice President, General Manager for the animal health division. He has spent the past 20 years in the pharmaceutical industry with strategic marketing, communications and operational management responsibilities.
Dr. Michael T. Collins
Michael T. Collins, DVM, PhD, Diplomate ACVM is a professor in the Department of Pathobiological Sciences at the University of Wisconsin School of Veterinary Medicine. He obtained his doctor of veterinary medicine degree from the University of Minnesota and his PhD from the University of Georgia. He has earned the prestigious title of Diplomate of the American College of Veterinary Microbiologists.